Potential Molecular Mechanism of Guishao Pingchan Recipe in the Treatment of Parkinson's Disease Based on Network Pharmacology and Molecular Docking

被引:0
|
作者
Tan, Li-Juan [1 ]
Yu, Ying [2 ]
Fang, Ze-Hai [3 ]
Zhang, Jiong-Lu [1 ]
Huang, Hai-Liang [4 ]
Liu, Hong-Jie [1 ]
机构
[1] Jinan Univ, Sch Tradit Chinese Med, Guangzhou 510632, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Innovat Inst Chinese Med & Pharm, Jinan, Peoples R China
[3] Zibo Vocat Inst, Sch Nursing, Zibo, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Coll Rehabil Med, Jinan 250355, Peoples R China
基金
中国国家自然科学基金;
关键词
Guishao Pingchan Recipe; Parkinson's disease; network pharmacology; molecular docking; biological information; ALPHA-SYNUCLEIN; BRAIN; INJURY; TETRAMETHYLPYRAZINE; NEUROPROTECTION; PAEONIFLORIN; DYSFUNCTION; PREDICTION; APOPTOSIS; PATHWAY;
D O I
10.1177/1934578X221118486
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: To investigate the potential mechanism of Guishao Pingchan Recipe (GPR) against Parkinson's disease (PD) based on network pharmacology and molecular docking. Methods: The main components of GPR were collected based on TCMSP database, Batman-TCM database, Chinese Pharmacopoeia, and Literatures. The potential therapeutic targets of PD were predicted by Drug Bank Database and Gene Cards database. Cytoscape 3.8.2 software was used to construct herb-component-target network. Then, String database was used to construct a PPI network, and DAVID database was used for gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation of targets function. Core components of GPR and hub targets were imported into AutoDock Vina for molecular docking verification and results were visualized by Pymol. Results: 13 candidate components were selected and 288 corresponding targets of GPR for treating PD were obtained. The GO enrichment analysis mainly involved 135 cell components, 187 molecular functions, and 1753 biological processes. Moreover, KEGG pathway enrichment analysis mainly involved 200 signaling pathways. Molecular docking simulation indicated a good binding ability of components and targets. Conclusion: Based on network pharmacology and molecular docking, we found that sitosterol, 4-Cholesten-3-one and stigmasterol in GPR could combine with MAPK3, APP, VEGFA, and CXCR4 and involved in the cAMP, PI3K/Akt, Rap1 signaling pathways. It is suggested that GPR may have therapeutic effects on PD through multi-component, multi-target, and multi-pathway and predict the relevant mechanism of the anti-PD effect of GPR.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Observational study on the potential mechanism of Sanao decoction in the treatment of asthma based on network pharmacology and molecular docking
    Chen, Wenpei
    Liu, Qiwei
    Gao, Xuyan
    Geng, Yingbao
    Kan, Hongxing
    MEDICINE, 2024, 103 (12) : E37592
  • [42] Mechanism of Radix Scutellariae in the treatment of influenza A based on network pharmacology and molecular docking
    Li, Qing
    Liu, Yuntao
    Yang, Min
    Jin, Lianshun
    Wu, Yali
    Tang, Lijuan
    He, Liuyun
    Wu, Dinghong
    Zhang, Zhongde
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (06)
  • [43] Network pharmacology and molecular docking reveal potential mechanism of esculetin in the treatment of ulcerative colitis
    Cai, Ting
    Cai, Bin
    MEDICINE, 2023, 102 (45) : E35852
  • [44] Exploring the active ingredients and potential mechanisms of Pingchan granules in Parkinson's disease treatment through network pharmacology and transcriptomics
    Xu, Qiu-Han
    Wang, Yi-Ling
    Wang, Cheng
    Jiang, Si-Si
    Zhang, Bao-Rong
    Tian, Jun
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [45] Study of the multitarget mechanism of Astragalus (HUANGQI) in the treatment of Alzheimer's disease based on network pharmacology and molecular docking technology
    Lv, Feng
    Sun, Mei
    Qin, Chunmeng
    Du, Dan
    Zheng, Xiangru
    Li, Wenjun
    PHARMACEUTICAL BIOLOGY, 2024, 62 (01) : 634 - 647
  • [46] Study on the Mechanism of Acori Graminei Rhizoma in th Treatment of Alzheimer's Disease Based on Network Pharmacology and Molecular Docking
    Du, Yi Kuan
    Xiao, Yue
    Zhong, Shao Min
    Huang, Yi Xing
    Chen, Qian Wen
    Zhou, Yu Qi
    Guo, Jin Yan
    Yang, Chun
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [47] Molecular mechanism of Spatholobi Caulis treatment for cholangiocarcinoma based on network pharmacology, molecular docking, and molecular dynamics simulation
    Chen, Xu
    Sun, Bo
    Zeng, Jia
    Yu, Zhangtao
    Liu, Jie
    Tan, Zhiguo
    Li, Yuhang
    Peng, Chuang
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (08) : 5789 - 5806
  • [48] Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder
    Liu, Yan-yun
    Yu, Li-hua
    Zhang, Juan
    Xie, Dao-jun
    Zhang, Xin-xiang
    Yu, Jia-ming
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [49] Exploring the Potential Molecular Mechanism of Sijunzi Decoction in the Treatment of Non-Segmental Vitiligo Based on Network Pharmacology and Molecular Docking
    Du, Ziwei
    Wang, Hepeng
    Gao, Yang
    Zheng, Shumao
    Kou, Xiaoli
    Sun, Guoqiang
    Song, Jinxian
    Dong, Jingfei
    Wang, Genhui
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 821 - 836
  • [50] Investigation into the potential mechanism and molecular targets of Fufang Xueshuantong capsule for the treatment of ischemic stroke based on network pharmacology and molecular docking
    Wang, Lei
    Wang, Liping
    Wang, Hui
    Zhu, Ting
    FRONTIERS IN PHARMACOLOGY, 2022, 13